Astera Labs (NASDAQ:ALAB) Stock Crosses Below 200 Day Moving Average – Time to Sell?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price passed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $255.22 and traded as low as $226.00. Astera Labs shares last traded at $229.67, with a volume of 5,469,500 shares changing hands.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q3 earnings of $1.32 per share beat the $1.19 consensus, while revenue of $584.9 million exceeded estimates and rose 153.6% year over year. Scorpio switches, including the X-Series, were a key growth driver. Article: Astera Labs Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management forecast Q4 revenue of $730 million to $750 million, citing AI connectivity demand. Expansion into optical connectivity, memory and rack-scale AI systems may provide additional growth opportunities. Article: ALAB Q3 Earnings Call Highlights Scorpio Ramp and New Growth Engines
• Neutral Sentiment: Analyst opinions were mixed: Northland upgraded ALAB to Outperform and Morgan Stanley raised its price target, while several firms lowered targets; RBC maintained an Outperform rating. Article: Northland Securities stock recommendations
• Negative Sentiment: Shares fell despite the earnings beat, suggesting results and guidance may not have been enough to satisfy expectations. Analysts flagged a premium valuation, rising costs, reliance on a limited number of customers and competition—particularly Marvell’s optical push—as risks to future growth. Article: Astera Labs Stock Falls Despite Strong Earnings. Its Growth Story Is Intact.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ALAB. Weiss Ratings cut Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research report on Friday, October 23rd. Morgan Stanley lifted their target price on Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a research report on Wednesday. Barclays lifted their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Needham & Company LLC cut their target price on Astera Labs from $425.00 to $300.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Susquehanna reduced their price target on Astera Labs from $310.00 to $258.00 and set a “neutral” rating for the company in a research report on Wednesday. Twelve equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $318.00.

Astera Labs Price Performance

The business’s 50-day moving average is $304.94 and its two-hundred day moving average is $255.78. The firm has a market cap of $38.74 billion, a P/E ratio of 102.46 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 27.30%. The firm had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. During the same period in the previous year, the firm posted $0.49 EPS. The company’s revenue for the quarter was up 153.6% on a year-over-year basis. Equities research analysts predict that Astera Labs, Inc. will post 2.71 EPS for the current year.

Insiders Place Their Bets

In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the transaction, the director directly owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the transaction, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 408,558 shares of company stock valued at $127,306,034 in the last quarter. 10.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs during the 2nd quarter worth $25,000. Archer Investment Corp bought a new stake in Astera Labs during the second quarter worth about $30,000. Transamerica Financial Advisors LLC bought a new stake in Astera Labs during the second quarter worth about $35,000. Continuum Advisory LLC bought a new stake in Astera Labs during the second quarter worth about $37,000. Finally, GK Wealth Management LLC acquired a new stake in Astera Labs during the third quarter worth about $29,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.